<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04074577</url>
  </required_header>
  <id_info>
    <org_study_id>19-00801</org_study_id>
    <nct_id>NCT04074577</nct_id>
  </id_info>
  <brief_title>Computer Aided Detection, Tandem Colonoscopy Study</brief_title>
  <official_title>Computer Aided Detection, Tandem Colonoscopy Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>NYU Langone Health</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>NYU Langone Health</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this project is to examine the role of machine learning and computer aided&#xD;
      diagnostics in automatic polyp detection and to determine in real-time how a computer-aided&#xD;
      detection (CADe) algorithm will perform when compared to standard screening or surveillance&#xD;
      colonoscopy alone. Design will be a multi-center, prospective, unblinded randomized tandem&#xD;
      colonoscopy study. 196 patients referred for either screening or surveillance colonoscopy&#xD;
      will be included.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">September 17, 2020</start_date>
  <completion_date type="Actual">October 14, 2020</completion_date>
  <primary_completion_date type="Actual">October 14, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Screening</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number of adenomas detected in combination technique compared to adenomas detected in standard technique Measured by Adenoma Miss Rate (AMR)</measure>
    <time_frame>1 Year</time_frame>
    <description>AMR will be calculated as the number of adenomas detected on the second pass or portion in either group divided by the total number of adenomas detected during both passes.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">32</enrollment>
  <condition>Colonic Diseases</condition>
  <arm_group>
    <arm_group_label>Standard Technique followed by Combination</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Back-to-back tandem colonoscopies by the same endoscopist using an Olympus 190 colonoscope. The first colonoscopy will be performed without automated polyp detection software (standard technique) followed immediately by another colonoscopy with automated polyp detection software (combination technique).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Combination +followed by Standard Technique</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Back-to-back tandem colonoscopies by the same endoscopist using an Olympus 190 colonoscope. In this arm, the first colonoscopy with be performed with automated polyp detection software (combination technique) followed immediately by another colonoscopy without automated polyp detection software (standard technique)</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Standard technique First</intervention_name>
    <description>colonoscopy without automated polyp detection software</description>
    <arm_group_label>Standard Technique followed by Combination</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>combination technique First</intervention_name>
    <description>automated polyp detection software</description>
    <arm_group_label>Combination +followed by Standard Technique</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients presenting to the endoscopy unit for a screening colonoscopy or a&#xD;
             surveillance colonoscopy&#xD;
&#xD;
          -  Willingness to undergo tandem colonscopies with and without the use of computer-aided&#xD;
             software while undergoing conventional colonoscopy with sedation&#xD;
&#xD;
          -  Ability to provide written, informed consent (approved by IRB) and understand the&#xD;
             responsibilities of trial participation&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  People with diminished cognitive capacity&#xD;
&#xD;
          -  Patients undergoing diagnostic colonoscopy (e.g. as an evaluation for active GI bleed)&#xD;
&#xD;
          -  Patients with incomplete colonoscopies (those where endoscopists did not successfully&#xD;
             intubate the cecum due to technical difficulties or poor bowel preparation)&#xD;
&#xD;
          -  Patients that have standard contraindications to colonoscopy in general (e.g.&#xD;
             documented acute diverticulitis, fulminant colitis and known or suspected&#xD;
             perforation).&#xD;
&#xD;
          -  Patients with inflammatory bowel disease&#xD;
&#xD;
          -  Patients referred for endoscopic mucosal resection (EMR)&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>22 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Seth Gross, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>New York Langone Health</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>NYU Langone Health</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10016</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>June 2021</verification_date>
  <study_first_submitted>August 29, 2019</study_first_submitted>
  <study_first_submitted_qc>August 29, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">August 30, 2019</study_first_posted>
  <last_update_submitted>June 28, 2021</last_update_submitted>
  <last_update_submitted_qc>June 28, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">June 29, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Colonic Diseases</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

